Discover BiomX's Q2 2025 updates, including progress in phage therapy trials BX004 & BX211, financial highlights, and key insights into upcoming ...

GAAP EPS was $(0.49) for Q2 2025, missing analyst estimates by 22.3%. Moleculin Biotech (NASDAQ:MBRX), a clinical-stage pharmaceutical developer focused on oncology, released its second quarter 2025 ...

Q2 2025 Earnings Call Transcript August 12, 2025 NeuroPace, Inc. misses on earnings expectations. Reported EPS is $-0.26 EPS, ...

Operator: Good evening, ladies and gentlemen, and welcome to the Verrica Pharmaceuticals Second Quarter 2025 Corporate Update ...

Getty Images Holdings, Inc. (NYSE: GETY) Q2 2025 Earnings Call Transcript August 11, 2025 Getty Images Holdings, Inc. misses ...

Q2 2025 Earnings Call Transcript August 11, 2025 BioCardia, Inc. beats earnings expectations. Reported EPS is $-0.4, ...

As of June 30, 2025, the Company had cash and cash equivalents and short-term deposits in the amount of $29.5 million, compared to $15.6 million on December 31, 2024. PolyPid expects that its current ...

A TikTok star was struck with severe diarrhoea while on a plane, and the aftermath was so bad that a full hazmat team was deployed and the next flight was cancelled. Meghan Reinertsen knew something ...

If you're hoping to play Madden 26 on PC, following our guide to the best video settings will help the game run as smooth as possible.

Armata achieved a major milestone with positive topline results from its Phase 1b/2a clinical trial of AP-SA02 for Staphylococcus aureus bacteremia. These 10 stocks could mint the next wave of ...

Hang on a second, let’s be careful what we’re talking about. It certainly looks like crimes. It certainly looks like war crimes. It may be systematic and crimes against humanity, but the definition of ...

Guidance now extends cash runway into the first half of 2028 versus the previous projection into 2027, following a $64 million capital raise. Strategic focus shifted further to internal development of ...